Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Feb 16, 2012; 4(2): 45-49
Published online Feb 16, 2012. doi: 10.4253/wjge.v4.i2.45
Table 1 Demographic and baseline characteristics of 221 patients
Gender (male/female)127/94
Age (yr) (mean ± SD)81 ± 14
Indication for PEG
CVA/CNSD/tumor136/77/8
Number of replacement
1127 (57%)
258 (26%)
3 and more36 (16%)
Time to replacement (d) (mean ± SD)271 ± 53
Type of catheter used previously
Bumper-tube-type106
Bumper-button-type103
Balloon-tube-type4
Balloon-button-type8
Table 2 Outcomes and complications of this percutaneous endoscopic gastrostomy replacement method
Successful procedure221 (100%)
Propofol dose (mg) (mean ± SD)(range)34 ± 11 (20-60)
Mean procedure time (range)(min)5.9 (3-8)
EGD findings newly recognized (%)
Reflux esophagitis12 (5.4)
Gastric ulcer5 (2.3)
Gastric neoplasm2 (0.9)
Duodenal ulcer1 (0.5)
Type of new catheters chosen
Bumper-tube-type112
Bumper-button-type109
Oxygen administered8 (3.6%)
Mask ventilation required0
Heart rate < 50 beats/min0
Blood pressure < 70 mmHg0
Discharge within 45 min after the procedure221 (100%)
Complications within 72 h of the procedure
Aspiration pneumonia0
Bleeding0
Perforation0
Peritonitis0
Table 3 Comparison of blood concentrations of propofol between PEG replacement patients and middle aged subjects who underwent esophagogastroduodenoscopy
PEG replacement(n = 20)Middle age (n=20)P value
Gender (M/F)10/1010/10
Age (yr)78 ± 252 ± 6< 0.0001
Body weight (kg)54 ± 957 ± 60.41
Dose used (mg)3060
Sedation level (moderate)2020
Blood propofol concentrations (ng/mL)
30 min after injection130 ± 36125 ± 350.55
60 min60 ± 2255 ± 190.47
120 min37 ± 1129 ± 140.45